DK1944298T3 - Quinazolinderivat og lægemiddel - Google Patents
Quinazolinderivat og lægemiddelInfo
- Publication number
- DK1944298T3 DK1944298T3 DK06811143.4T DK06811143T DK1944298T3 DK 1944298 T3 DK1944298 T3 DK 1944298T3 DK 06811143 T DK06811143 T DK 06811143T DK 1944298 T3 DK1944298 T3 DK 1944298T3
- Authority
- DK
- Denmark
- Prior art keywords
- medicinal products
- quinazoline derivatives
- quinazoline
- derivatives
- medicinal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005290416 | 2005-10-03 | ||
| PCT/JP2006/319803 WO2007040231A1 (ja) | 2005-10-03 | 2006-10-03 | キナゾリン誘導体及び医薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1944298T3 true DK1944298T3 (da) | 2013-02-11 |
Family
ID=37906272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06811143.4T DK1944298T3 (da) | 2005-10-03 | 2006-10-03 | Quinazolinderivat og lægemiddel |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8431586B2 (da) |
| EP (1) | EP1944298B1 (da) |
| JP (1) | JP4803181B2 (da) |
| KR (1) | KR101323083B1 (da) |
| CN (1) | CN101304979B (da) |
| AU (1) | AU2006298073A1 (da) |
| BR (1) | BRPI0616682A2 (da) |
| CA (1) | CA2624141C (da) |
| CY (1) | CY1113801T1 (da) |
| DK (1) | DK1944298T3 (da) |
| ES (1) | ES2402060T3 (da) |
| PL (1) | PL1944298T3 (da) |
| PT (1) | PT1944298E (da) |
| RU (1) | RU2464263C2 (da) |
| SI (1) | SI1944298T1 (da) |
| WO (1) | WO2007040231A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013051159A1 (en) * | 2011-10-05 | 2013-04-11 | Nippon Shinyaku Co., Ltd. | Nop receptor antagonist |
| CN102659692B (zh) | 2012-05-04 | 2014-04-09 | 郑州泰基鸿诺药物科技有限公司 | 双联厄洛替尼及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2256654C2 (ru) * | 1999-01-22 | 2005-07-20 | Кирин Бир Кабусики Кайся | Хинолиновые и хиназолиновые производные |
| ATE449084T1 (de) * | 2000-03-31 | 2009-12-15 | Nippon Shinyaku Co Ltd | Derivate von heterocyclen und arzneistoffe |
| JP2002138052A (ja) | 2000-10-31 | 2002-05-14 | Nippon Oruganon Kk | 掻痒治療薬 |
| US20040116450A1 (en) * | 2001-03-19 | 2004-06-17 | Tatsuya Oyama | Antipruritics |
| JP2003201250A (ja) | 2001-10-22 | 2003-07-18 | Santen Pharmaceut Co Ltd | 掻痒治療剤 |
| TWI250023B (en) * | 2001-10-22 | 2006-03-01 | Santen Pharmaceutical Co Ltd | Pharmaceutical composition for itch treating agent |
| US7718663B2 (en) * | 2002-04-26 | 2010-05-18 | Nippon Shinyaku Co., Ltd. | Quinazoline derivatives and medicaments |
| MXPA04004371A (es) * | 2002-08-09 | 2004-08-13 | Taisho Pharmaceutical Co Ltd | Agente antipruritico. |
| US7737182B2 (en) * | 2002-08-09 | 2010-06-15 | Taisho Pharmaceutical Co., Ltd. | Pharmaceuticals for xerosis |
| JP2005139194A (ja) | 2002-08-09 | 2005-06-02 | Taisho Pharmaceut Co Ltd | 止痒剤 |
| JP2004107209A (ja) | 2002-09-13 | 2004-04-08 | Nippon Oruganon Kk | 掻痒治療薬 |
| US20040243341A1 (en) * | 2003-05-30 | 2004-12-02 | Le Cocq Christian A. | Feature extraction methods and systems |
| US20060258703A1 (en) * | 2003-07-17 | 2006-11-16 | Ono Pharmaceutical Co., Ltd. | Remedy for pruritus comprising piperidine derivative as the active ingredient |
| JP2005047909A (ja) | 2003-07-17 | 2005-02-24 | Santen Pharmaceut Co Ltd | ピペリジン誘導体を有効成分とする掻痒治療剤 |
-
2006
- 2006-10-03 ES ES06811143T patent/ES2402060T3/es active Active
- 2006-10-03 BR BRPI0616682-2A patent/BRPI0616682A2/pt not_active Application Discontinuation
- 2006-10-03 WO PCT/JP2006/319803 patent/WO2007040231A1/ja active Application Filing
- 2006-10-03 JP JP2007538770A patent/JP4803181B2/ja active Active
- 2006-10-03 EP EP06811143A patent/EP1944298B1/en active Active
- 2006-10-03 RU RU2008117383/04A patent/RU2464263C2/ru not_active IP Right Cessation
- 2006-10-03 CA CA2624141A patent/CA2624141C/en active Active
- 2006-10-03 KR KR1020087010504A patent/KR101323083B1/ko active IP Right Grant
- 2006-10-03 SI SI200631553T patent/SI1944298T1/sl unknown
- 2006-10-03 PL PL06811143T patent/PL1944298T3/pl unknown
- 2006-10-03 US US12/089,087 patent/US8431586B2/en active Active
- 2006-10-03 DK DK06811143.4T patent/DK1944298T3/da active
- 2006-10-03 PT PT68111434T patent/PT1944298E/pt unknown
- 2006-10-03 CN CN2006800421502A patent/CN101304979B/zh active Active
- 2006-10-03 AU AU2006298073A patent/AU2006298073A1/en not_active Abandoned
-
2013
- 2013-03-13 CY CY20131100220T patent/CY1113801T1/el unknown
- 2013-04-02 US US13/855,096 patent/US8835446B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007040231A1 (ja) | 2007-04-12 |
| CN101304979B (zh) | 2012-08-15 |
| US8835446B2 (en) | 2014-09-16 |
| PT1944298E (pt) | 2013-02-13 |
| US20100022566A1 (en) | 2010-01-28 |
| CA2624141A1 (en) | 2007-04-12 |
| US20130225613A1 (en) | 2013-08-29 |
| CA2624141C (en) | 2014-07-08 |
| EP1944298A4 (en) | 2010-06-30 |
| JPWO2007040231A1 (ja) | 2009-04-16 |
| AU2006298073A1 (en) | 2007-04-12 |
| EP1944298A1 (en) | 2008-07-16 |
| CN101304979A (zh) | 2008-11-12 |
| BRPI0616682A2 (pt) | 2011-06-28 |
| KR101323083B1 (ko) | 2013-10-29 |
| EP1944298B1 (en) | 2013-01-09 |
| KR20080053951A (ko) | 2008-06-16 |
| RU2464263C2 (ru) | 2012-10-20 |
| SI1944298T1 (sl) | 2013-05-31 |
| PL1944298T3 (pl) | 2013-07-31 |
| ES2402060T3 (es) | 2013-04-26 |
| US8431586B2 (en) | 2013-04-30 |
| JP4803181B2 (ja) | 2011-10-26 |
| RU2008117383A (ru) | 2009-11-10 |
| CY1113801T1 (el) | 2016-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1894567T3 (da) | Ledsagende farmaceutiske midler og anvendelse deraf | |
| MA29039B1 (fr) | Dibenzylamines et derives | |
| DE602006013492D1 (de) | Verfahren und zwischenprodukte | |
| DK2049525T3 (da) | N-laminoheteroaryl)-1H-indol-2-carboxamid-derivater, og fremstilling og terapeutisk anvendelse deraf | |
| DE602006005539D1 (de) | Ernährungsschlauch und Schiene | |
| DK1620118T3 (da) | Reversible pegylerede lægemidler | |
| IS2504B (is) | Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra | |
| NO20054709L (no) | Sammenfoyningssystem og anvendelse av dette | |
| DE602005015349D1 (de) | Verbesserte kautschukmodifizierte monovinyliden-aromapolymere und daraus hergestellte erzeugnisse | |
| IL190292A (en) | History of pyridopyrimidinone and their pharmaceutical preparations | |
| PL1919894T3 (pl) | Nowe pochodne polichinolin i ich zastosowanie terapeutyczne | |
| PL1861387T3 (pl) | Pochodne benzoimidazolu i ich kompozycje farmaceutyczne | |
| DK1922309T3 (da) | N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf | |
| DK1885716T3 (da) | Thiazolderivater og anvendelse deraf | |
| DK1957073T3 (da) | Lægemiddel | |
| DK1771421T3 (da) | N-hydroxyamidderivater og anvendelse deraf | |
| ATE420081T1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
| PT1861387E (pt) | Derivados de benzimidazol e composições farmacêuticas dos mesmos | |
| GB0516069D0 (en) | Pharmaceutical and use thereof | |
| EP1873147A4 (en) | PHTHALAZINON DERIVATIVE AND THEREOF PHARMACEUTICALS | |
| DK1773829T3 (da) | Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf | |
| DK1828137T3 (da) | 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter | |
| DK1940840T3 (da) | 6-heteroarylpyridoindolon-derivater, fremstilling deraf og terapeutisk anvendelse deraf | |
| DK1791872T3 (da) | Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf | |
| DK2029561T3 (da) | Tricyclisk forbindelse og farmaceutisk anvendelse deraf |